NASA Notice of Prospective Patent License: Regenetech, Inc.
[Federal Register: September 29, 2003 (Volume 68, Number 188)]
[Notices]
[Page 56016-56017]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29se03-130]
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice (03-116)]
Notice of Prospective Patent License
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of prospective patent license.
SUMMARY: NASA hereby gives notice that Regenetech, Inc., of Sugar Land,
TX, has applied for a partially exclusive license to practice the
inventions described and claimed in U.S. Patent No. 6,485,963, “Growth
Stimulation of Biological Cells and Tissue by Electromagnetic Fields
and Uses Thereof; U.S. Patent No. 5,153,132, entitled “Three-
Dimensional Co-Culture Process;” U.S. Patent No. 5,153,133, entitled
“Method for Culturing Mammalian Cells in a Horizontally Rotated
Bioreactor;” U.S. Patent No. 5,155,034, entitled “Three-Dimensional
Cell to Tissue Assembly Process;” U.S. Patent No. 5,155,035, entitled
“Method for Culturing Mammalian Cells in a Perfused Bioreactor;” U.S. Patent No. 5,308,764, entitled “Multi-
Cellular Three-Dimensional Living Mammalian Tissue;” U.S. Patent No.
5,496,722, entitled “Method for Producing Non-Neoplastic, 3-
Dimensional Mammalian Tissue and Cell Aggregates under Microgravity
Culture Conditions and the Products Produced Thereby;” U.S. Patent No.
5,627,021, entitled “Multi-Cellular, Three-Dimensional Living
Mammalian Tissue;” U.S. Patent No. 5,846,807, entitled “Media
Compositions for Three Dimensional Mammalian Tissue Growth Under
Microgravity Culture Conditions;” U.S. Patent No. 5,858,783, entitled
“Production of Normal Mammalian Organ Culture Using a Medium
Containing MemAlpha, Leibovitz L-15, Glucose Galactose Fructose;” U.S.
Patent No. 5,851,816, entitled “Cultured High-Fidelity Three
Dimensional Human Urogenital Tract Carcinomas and Process;” and U.S.
Patent No. 6,117,674, entitled “Horizontal Rotating-Wall Vessel
Propagation in Vitro Human Tissue Models; “ and pending patent
application identified as NASA Case No. MSC-22633-2, “Growth
Stimulation of Biological Cells and Tissue by Electromagnetic Fields
and Uses Thereof.” Each of the above U.S. Patents and the patent
application are assigned to the United States of America as represented
by the Administrator of the National Aeronautics and Space
Administration. Written objections to the prospective grant of a
license should be sent to the Johnson Space Center.
DATES: Responses to this notice must be received by October 14, 2003.
FOR FURTHER INFORMATION CONTACT: James Cate, Patent Attorney, NASA
Johnson Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone
(281) 483-1001.
Dated: September 23, 2003.
Robert M. Stephens,
Deputy General Counsel.
[FR Doc. 03-24531 Filed 9-26-03; 8:45 am]
BILLING CODE 7510-01-P
